APELLIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.86 USD | +4.03% |
|
+4.90% | -16.71% |
Chart calendar Apellis Pharmaceuticals, Inc.
0e8a4152a.aMPyTK8fJtklxD7e_8UJCOxe-xliXalicTFIAHTom3U.OvTEJpdtboEVlhO3oIFuY9kJkyouENoPBVxxZCWO1S8dtZ4Y63REjxaBfw~0b9da5942584d4c316fabc0c724044b3
Upcoming events on Apellis Pharmaceuticals, Inc.
Past events on Apellis Pharmaceuticals, Inc.
| 08/04/2024 10:15 pm | Needham Healthcare Conference |
| 05/03/2024 09:30 pm | Raymond James Institutional Investors Conference - Fireside Chat |
| 05/03/2024 07:40 pm | TD Cowen Health Care Conference - Panel |
| 05/03/2024 12:40 am | TD Cowen Health Care Conference - Fireside Chat |
| 27/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 27/02/2024 05:35 pm | Q4 2023 Earnings Release |
| 08/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 05/01/2024 12:55 am | Goldman Sachs Healthcare C-Suite Unscripted Conference - Fireside Chat |
| 14/12/2023 07:00 pm | Business Update Call |
| 28/11/2023 08:30 pm | Evercore ISI HealthCONx Conference |
| 04/11/2023 07:30 pm | American Society of Nephrology Kidney Conference - Poster #SA-PO923 |
| 01/11/2023 05:30 pm | Q3 2023 Earnings Call |
| 01/11/2023 04:35 pm | Q3 2023 Earnings Release |
| 13/09/2023 12:30 am | H.C. Wainwright Global Investment Conference |
| 12/09/2023 09:45 pm | Baird Global Healthcare Conference |
| 11/09/2023 07:30 pm | Morgan Stanley Global Healthcare Conference |
| 08/09/2023 07:00 pm | Wells Fargo Healthcare Conference |
| 06/09/2023 07:10 pm | Citi BioPharma Conference |
| 01/08/2023 01:35 am | American Society of Retina Meeting |
| 31/07/2023 06:00 pm | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 251 98,4 154.61% | 66,6 15,0 343.57% | 75,4 77,7 -2.87% | 397 392 1.15% | 793 |
|
EBITDA Million USD | Released Forecast Spread | -288 -247 -16.61% | -213 -377 43.41% | -535 -560 4.52% | -593 -587 -0.96% | -515 -524 1.66% | -74,2 |
|
EBIT Million USD | Released Forecast Spread | -288 -255 -13.08% | -214 -373 42.68% | -536 -580 7.58% | -595 -590 -0.7% | -517 -513 -0.8% | -106 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -305 -263 -15.69% | -343 -449 23.62% | -746 -736 -1.29% | -652 -660 1.3% | -526 -523 -0.69% | -116 |
|
Net income Million USD | Released Forecast Spread | -305 -264 -15.43% | -345 -458 24.78% | -746 -724 -3.12% | -652 -660 1.17% | -529 -525 -0.72% | -121 |
|
EPS USD | Released Forecast Spread | -4,90 -4,23 -15.73% | -4,59 -5,95 22.84% | -8,84 -8,66 -2.06% | -6,15 -6,27 1.97% | -4,45 -4,44 -0.23% | -1,00 |
| Announcement Date | 27/02/20 | 25/02/21 | 28/02/22 | 21/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,3 8,78 586.34% | 14,4 12,6 13.94% | 16,3 16,9 -3.68% | 22,1 21,6 2.15% | 22,7 24,5 -7.57% | 44,8 26,1 71.79% | 95,0 71,1 33.53% | 110 99,1 11.45% | 146 144 1.94% | 162 | 189 | 213 | 236 | 284 |
|
EBITDA Million USD | Released Forecast Spread | -89,0 -121 26.23% | -129 -105 -22.42% | -148 -116 -27.69% | -153 -126 -20.75% | -164 -134 -21.73% | -175 -155 -13.01% | -120 -149 19.59% | -137 -93,0 -46.86% | -84,0 -125 32.84% | -54,7 | -37,1 | -23,9 | -6,83 | |
|
EBIT Million USD | Released Forecast Spread | -89,4 -137 34.85% | -129 -129 -0.03% | -149 -138 -7.82% | -153 -151 -1.28% | -164 -154 -6.55% | -175 -169 -3.46% | -120 -153 21.44% | -137 -114 -19.81% | -84,5 -79,5 -6.29% | -61,3 | -37,3 | -18,2 | 0,85 | 56,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -148 -136 -8.94% | -138 -126 -9.08% | -155 -141 -9.95% | -191 -157 -21.16% | -167 -162 -3.31% | -177 -163 -8.97% | -122 -151 19.54% | -140 -99,7 -40.4% | -87,2 -76,3 -14.27% | -56,5 | -43,1 | -25,1 | -6,46 | 55,4 |
|
Net income Million USD | Released Forecast Spread | -148 -133 -11.53% | -139 -130 -6.95% | -156 -144 -8.28% | -191 -158 -20.8% | -166 -172 3.51% | -178 -165 -7.56% | -122 -153 20.37% | -140 -103 -36.48% | -88,6 -79,7 -11.1% | -56,5 | -43,1 | -25,2 | -6,71 | 53,8 |
|
EPS USD | Released Forecast Spread | -1,61 -1,49 -8.14% | -1,42 -1,30 -8.91% | -1,46 -1,37 -6.42% | -1,75 -1,46 -19.61% | -1,50 -1,56 4.1% | -1,56 -1,46 -6.78% | -1,02 -1,32 22.67% | -1,17 -0,86 -36.15% | -0,73 -0,69 -6.41% | -0,47 | -0,35 | -0,21 | -0,06 | 0,19 |
| Announcement Date | 28/02/22 | 04/05/22 | 08/08/22 | 07/11/22 | 21/02/23 | 04/05/23 | 31/07/23 | 01/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Apellis Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APLS Stock
- Calendar Apellis Pharmaceuticals, Inc.
